Contact your PlexusDx provider before making the change to ensure it aligns with your treatment plan
Less commonly used glucose-lowering medications Alpha-glucosidase inhibitors improve glycaemic control by reducing postprandial glycaemic excursions and glycaemic variability and may provide specific benefits in cultures and settings with high carbohydrate consumption or reactive hypoglycaemia [221, 222]
Available from: Esposito, F., Morisco, F., Verde, V., Ritieni, A., Alezio, A., Caporaso, N., & Fogliano, V
Int J Eat Disord (2012) 45(3):33344
Cosmos Limited is proud to announce that we officially launched Glucoset Kenyas first oral Semaglutide (3mg | 7mg | 14mg Tablets), for the management of Type 2 Diabetes